Methylprednisolone Acetate
Product Images NDC 0781-3516

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Acetate (NDC 0781-3516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mpa Structure (Mpa Structure)

Chemical structure diagram of methylprednisolone acetate, showing its steroid backbone with functional groups including hydroxyl, ketone, and acetate ester moieties.*

FDA Label Image

80mg-label (80mg 5ml Label)

Label for METHYLPREDNISOLONE ACETATE Injectable Suspension, USP with strength 400 mg/5 mL (80 mg/mL) in a 5 mL multiple-dose vial. Distributed by Sandoz Inc., the label specifies use for intramuscular, intrasynovial, and soft tissue injection only, contains benzyl alcohol as a preservative, and includes dosage and use instructions referring to accompanying prescribing information.*

FDA Label Image

80mg-carton (80mg 5ml Carton)

Packaging label for Methylprednisolone Acetate Injectable Suspension, USP 400 mg/5 mL (80 mg/mL) by Sandoz Inc. The label shows this is a 5 mL multiple-dose vial for intramuscular, intrasynovial, and soft tissue injection only, not for intravenous use. Benzyl Alcohol is listed as a preservative. The product is distributed by Sandoz Inc., Princeton, NJ, and is made in Spain.*

FDA Label Image

40mg-5ml-carton (40mg 5ml Carton)

METHYLPREDNISOLONE ACETATE 200 mg/5 mL (40 mg/mL) Injectable Suspension carton label from Sandoz Inc. The label states it is for intramuscular, intrasynovial, and soft tissue injection only, preserving benzyl alcohol as a preservative. The 5 mL multiple-dose vial packaging includes storage instructions and a list of inactive ingredients.*

FDA Label Image

40mg-label (40mg 5ml Label)

Label for Methylprednisolone Acetate Injectable Suspension, USP, 200 mg/5 mL (40 mg/mL) in a 5 mL multiple-dose vial. Distributed by Sandoz Inc. The label includes usage instructions restricting administration to intramuscular, intrasynovial, and soft tissue injections, not intravenous use. It contains benzyl alcohol as a preservative and advises shaking before use. The label displays the NDC 0781-3522-75 and a barcode.*

FDA Label Image

40mg-10ml-carton (40mg 10ml Carton)

Packaging label for Methylprednisolone Acetate Injectable Suspension, USP by Sandoz Inc. The label indicates a concentration of 400 mg/10 mL (40 mg/mL) in a 10 mL multiple-dose vial. It is labeled for intramuscular, intrasynovial, and soft tissue injection only, not for intravenous use. The label includes storage instructions, a list of inactive ingredients including benzyl alcohol as a preservative, and states the product is distributed by Sandoz Inc. in Princeton, NJ, and made in Spain.*

FDA Label Image

40mg-5ml-label (40mg 10ml Label)

Label for METHYLPREDNISOLONE ACETATE Injectable Suspension, USP 400 mg/10 mL (40 mg/mL) in a 10 mL multiple-dose vial. Distributed by Sandoz Inc., Princeton, NJ. The label includes usage instructions and warnings, noting it is for intramuscular, intrasynovial, and soft tissue injection only, not for intravenous use, and contains benzyl alcohol as a preservative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.